2024
World addiction medicine reports: formation of the International Society of Addiction Medicine Global Expert Network (ISAM-GEN) and its global surveys
Ekhtiari H, Khojasteh Zonoozi A, Rafei P, Abolghasemi F, Pemstein D, Abdelgawad T, Achab S, Ghafri H, Al'Absi M, Bisch M, Conti A, Ambekar A, Arunogiri S, Bhad R, Bilici R, Brady K, Bunt G, Busse A, Butner J, Danesh A, El-Khoury J, Omari F, Jokūbonis D, de Jong C, Dom G, Ebrahimi M, Fathi Jouzdani A, Ferri M, Galea-Singer S, Parker D, Higuchi S, Kathiresan P, Khelifa E, Kouimtsidis C, Krupitsky E, Long J, Maremmani I, McGovern G, Mohaddes Ardabili H, Rahimi-Movaghar A, Rataemane S, Sangchooli A, Sibeko G, Vella A, Vista S, Zare-Bidoky M, Zhao M, Javed A, Potenza M, Baldacchino A. World addiction medicine reports: formation of the International Society of Addiction Medicine Global Expert Network (ISAM-GEN) and its global surveys. Frontiers In Psychiatry 2024, 15: 1230318. PMID: 38528974, PMCID: PMC10961370, DOI: 10.3389/fpsyt.2024.1230318.Peer-Reviewed Original Research
2017
Onsite treatment of HCV infection with direct acting antivirals within an opioid treatment program
Butner JL, Gupta N, Fabian C, Henry S, Shi JM, Tetrault JM. Onsite treatment of HCV infection with direct acting antivirals within an opioid treatment program. Journal Of Substance Use And Addiction Treatment 2017, 75: 49-53. PMID: 28237054, DOI: 10.1016/j.jsat.2016.12.014.Peer-Reviewed Original ResearchConceptsDirect acting antiviralsOpioid treatment programsPercent of patientsHCV treatmentHCV infectionActing antiviralsTreatment outcomesTreatment programOral HCV treatmentSustained virologic responseHCV treatment outcomesRoutine clinical careOngoing drug useVirologic responseRetrospective studyClinical careGeneral populationPatientsDrug useTreatmentOutcomesAntiviralsInfectionPercentPWID